Detail akcie Trellus Hlth Rg online

Business Summary: Trellus Health plc is a United Kingdom-based healthcare company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Company’s Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevate’s personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Company’s wholly owned subsidiary is Trellus Health Inc.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Trellus Health PLC revenues increased from $50K to $295K. Net loss decreased 23% to $3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Administrative expenses - Balancing valu decrease of 22% to $2.9M (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -$0.02.